Soluble urokinase-type plasminogen activator receptor forms in plasma as markers of atherosclerotic plaque vulnerability

This publication has 27 references indexed in Scilit:

• Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
  Clinical Immunology, 2009
• Histological Assessment of 526 Symptomatic Carotid Plaques in Relation to the Nature and Timing of Ischemic Symptoms
  Circulation, 2006
• Enhanced Discrimination of Benign from Malignant Prostatic Disease by Selective Measurements of Cleaved Forms of Urokinase Receptor in Serum
  Clinical Chemistry, 2006
• Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients
  Journal of Vascular Surgery, 2005
• Act Local, Act Global⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
  JACC, 2005
• Plasma Concentrations of Soluble Urokinase‐Type Plasminogen Activator Receptor Are Increased in Patients with Malaria and Are Associated with a Poor Clinical or a Fatal Outcome
  The Journal of Infectious Diseases, 2005
• Specific Immunoassays for Detection of Intact and Cleaved Forms of the Urokinase Receptor
  Clinical Chemistry, 2004
• Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions
  Blood Coagulation & Fibrinolysis, 2004
• Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection
  Kidney International, 2003
• Prognosis after Transient Monocular Blindness Associated with Carotid-Artery Stenosis
  New England Journal of Medicine, 2001